U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Lyons-Williams Lori (0001693564)
Mailing Address
C/O DERMIRA, INC.
275 MIDDLEFIELD ROAD, SUITE 150
MENLO PARK CA 94025
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Contineum Therapeutics, Inc. 0001855175 2024-04-04 director
RAPT Therapeutics, Inc. 0001673772 2021-11-09 director
FIVE PRIME THERAPEUTICS INC
Current Name:FIVE PRIME THERAPEUTICS, INC.		 0001175505 2019-06-23 director
Dermira, Inc. 0001557883 2016-12-12 officer: Chief Commercial Officer


Items 1 - 38

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-05-24   Contineum Therapeutics, Inc. 4 A-Award --D 29500.0000 29500.0000 1 0001855175 Stock Option (right to buy)
A 2024-05-22   RAPT Therapeutics, Inc. 4 A-Award --D 36490.0000 36490.0000 1 0001673772 Stock Option (right to buy)
A 2023-05-24   RAPT Therapeutics, Inc. 4 A-Award --D 12940.0000 12940.0000 1 0001673772 Stock Option (right to buy)
A 2022-05-25   RAPT Therapeutics, Inc. 4 A-Award --D 8500.0000 8500.0000 1 0001673772 Stock Option (right to buy)
A 2021-11-09   RAPT Therapeutics, Inc. 4 A-Award --D 22500.0000 22500.0000 1 0001673772 Stock Option (right to buy)
D 2021-04-16   FIVE PRIME THERAPEUTICS, INC. 4 D-Return --D 20000.0000 0.0000 2 0001175505 Stock Option (right to buy)
D 2021-04-16   FIVE PRIME THERAPEUTICS, INC. 4 D-Return --D 25000.0000 0.0000 1 0001175505 Stock Option (right to buy)
A 2020-05-14   FIVE PRIME THERAPEUTICS, INC. 4 A-Award --D 20000.0000 20000.0000 1 0001175505 Stock Option (right to buy)
D 2020-02-20   Dermira, Inc. 4 D-Return --D 15000.0000 0.0000 7 0001557883 Restricted Stock Unit
D 2020-02-20   Dermira, Inc. 4 D-Return --D 30000.0000 0.0000 6 0001557883 Restricted Stock Unit
D 2020-02-20   Dermira, Inc. 4 D-Return --D 6378.0000 0.0000 5 0001557883 Restricted Stock Unit
D 2020-02-20   Dermira, Inc. 4 D-Return --D 65000.0000 0.0000 4 0001557883 Employee Stock Options (Right to buy)
D 2020-02-20   Dermira, Inc. 4 D-Return --D 63750.0000 0.0000 3 0001557883 Employee Stock Options (Right to buy)
D 2020-02-20   Dermira, Inc. 4 D-Return --D 100000.0000 0.0000 2 0001557883 Employee Stock Options (Right to buy)
D 2020-02-20   Dermira, Inc. 4 D-Return --D 25401.0000 0.0000 1 0001557883 Common Stock
D 2019-08-15   Dermira, Inc. 4 M-Exempt --D 3189.0000 6378.0000 3 0001557883 Restricted Stock Unit
D 2019-08-15   Dermira, Inc. 4 F-InKind --D 1582.0000 25401.0000 2 0001557883 Common Stock
A 2019-08-15   Dermira, Inc. 4 M-Exempt --D 3189.0000 26983.0000 1 0001557883 Common Stock
A 2019-06-23   FIVE PRIME THERAPEUTICS INC 4 A-Award --D 25000.0000 25000.0000 1 0001175505 Stock Option (right to buy)
D 2019-05-17   Dermira, Inc. 4 M-Exempt --D 30000.0000 30000.0000 3 0001557883 Restricted Stock Unit
D 2019-05-17   Dermira, Inc. 4 F-InKind --D 10374.0000 23794.0000 2 0001557883 Common Stock
A 2019-05-17   Dermira, Inc. 4 M-Exempt --D 30000.0000 34168.0000 1 0001557883 Common Stock
A 2019-02-12   Dermira, Inc. 4 A-Award --D 15000.0000 15000.0000 3 0001557883 Restricted Stock Unit
A 2019-02-12   Dermira, Inc. 4 A-Award --D 65000.0000 65000.0000 2 0001557883 Employee Stock Options (Right to buy)
D 2018-08-15   Dermira, Inc. 4 M-Exempt --D 1063.0000 9567.0000 4 0001557883 Restricted Stock Unit
A 2018-08-15   Dermira, Inc. 4 M-Exempt --D 1063.0000 2984.0000 1 0001557883 Common Stock
D 2018-08-15   Dermira, Inc. 4 F-InKind --D 368.0000 2616.0000 2 0001557883 Common Stock
A 2018-08-15   Dermira, Inc. 4 A-Award --D 60000.0000 60000.0000 3 0001557883 Restricted Stock Unit
A 2018-02-15   Dermira, Inc. 4 A-Award --D 10630.0000 10630.0000 3 0001557883 Restricted Stock Unit
A 2018-02-15   Dermira, Inc. 4 A-Award --D 63750.0000 63750.0000 2 0001557883 Employee Stock Options (Right to buy)
A 2017-01-09   Dermira, Inc. 4 A-Award --D 100000.0000 100000.0000 1 0001557883 Employee Stock Options (Right to buy)
- -   Dermira, Inc. 4 - --D 2617.0000 1 0001557883 Common Stock
- -   FIVE PRIME THERAPEUTICS INC 3 - --- 1 - -
- -   RAPT Therapeutics, Inc. 3 - --D 1 0001673772 Stock Option (right to buy)
- -   Dermira, Inc. 3 - --- 1 - -
- -   Contineum Therapeutics, Inc. 3 - --I 1 0001855175 Stock Option (right to buy)
- -   Contineum Therapeutics, Inc. 3 - --I 2 0001855175 Stock Option (right to buy)
- -   Dermira, Inc. 4 - --D 879.0000 1 0001557883 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016